miR-1262 Transcriptionally Modulated by an Enhancer Genetic Variant Improves Efficiency of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Advanced Lung Adenocarcinoma

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Genetic Variant ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma

JAMA Oncology ◽

10.1001/jamaoncol.2021.7015 ◽

2022 ◽

Author(s):

Oscar Arrieta ◽

Zyanya Lucia Zatarain-Barrón ◽

Jenny G. Turcott ◽

Feliciano Barrón ◽

Sai Yendamuri ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Chemotherapy ◽

10.1159/000321490 ◽

2011 ◽

Vol 57 (2) ◽

pp. 108-114 ◽

Cited By ~ 1

Author(s):

Seung Tae Kim ◽

Yoon Ji Choi ◽

Kyong Hwa Park ◽

Sang Cheul Oh ◽

Jae Hong Seo ◽

...

Keyword(s):

Growth Factor ◽

Prognostic Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

Pathology & Oncology Research ◽

10.1007/s12253-013-9715-0 ◽

2013 ◽

Vol 20 (2) ◽

pp. 445-451 ◽

Cited By ~ 9

Author(s):

Rong-li Lu ◽

Cheng-Ping Hu ◽

Hua-ping Yang ◽

Yuan-yuan Li ◽

Qi-hua Gu ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling

Frontiers in Oncology ◽

10.3389/fonc.2020.542007 ◽

2020 ◽

Vol 10 ◽

Author(s):

Jinfang Cui ◽

Yang Song ◽

Xuejiao Han ◽

Jing Hu ◽

Yanbo Chen ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma

OncoTargets and Therapy ◽

10.2147/ott.s136569 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4135-4141

Author(s):

Hisashi Saji ◽

Hiroki Sakai ◽

Hiroyuki Kimura ◽

Tomoyuki Miyazawa ◽

Hideki Marushima ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Staging System ◽

Epidermal Growth ◽

Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2013.74.3.129 ◽

2013 ◽

Vol 74 (3) ◽

pp. 129 ◽

Cited By ~ 1

Author(s):

Eun-Young Kim ◽

Yoon-Hee Kim ◽

Hee-Jung Ban ◽

In-Jae Oh ◽

Yong-Soo Kwon ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients

Pharmacogenomics and Personalized Medicine ◽

10.2147/pgpm.s329055 ◽

2021 ◽

Vol Volume 14 ◽

pp. 1291-1302

Author(s):

Ji Eun Park ◽

Mi Jeong Hong ◽

Shin Yup Lee ◽

Jang Hyuck Lee ◽

Jin Eun Choi ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Genetic Variant ◽

Growth Factor Receptor ◽

Nuclear Pore ◽

Epidermal Growth ◽

Leukocyte Telomere Length and Clinical Outcomes of Advanced Lung Adenocarcinoma Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment

DNA and Cell Biology ◽

10.1089/dna.2018.4337 ◽

2018 ◽

Vol 37 (11) ◽

pp. 903-908

Author(s):

Ji Li ◽

Li Zhang ◽

Hui Zhu ◽

Wenting Pan ◽

Nasha Zhang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Leukocyte Telomere Length ◽

Epidermal Growth ◽

Small‐Molecule Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

The Oncologist ◽

10.1634/theoncologist.8-6-576 ◽

2003 ◽

Vol 8 (6) ◽

pp. 576-586 ◽

Cited By ~ 46

Author(s):

Maarten L. Janmaat ◽

Giuseppe Giaccone

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Small Molecule ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer

Molecular Cancer ◽

10.1186/s12943-018-0785-1 ◽

2018 ◽

Vol 17 (1) ◽

Cited By ~ 4

Author(s):

Yuan-Chin Tsai ◽

Tao Zeng ◽

Wassim Abou-Kheir ◽

Hsiu-Lien Yeh ◽

Juan Juan Yin ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽